Inventor · disambiguated record
Ingo Lang
Also filed as: LANG INGO · LANG INGO ULRICH
12 granted patents·15 pending applications·16 citations·filing 2005–2024
88Inventor score
Files withBOEHRINGER INGELHEIM VETMEDICA GMBH15BOEHRINGER INGELHEIM VETMED5STARK MARCUS3AVEN MICHAEL1DE VRIES FRERICH1
Top patents by PatentIndex Score
27 records- 0180US10357479B2Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in catsBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2018·Granted Jul 23, 2019·2 cites·13 claims
- 0279US9949954B2Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in catsBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2017·Granted Apr 24, 2018·2 cites·13 claims
- 0377US11826378B2Use of SGLT-2 inhibitors for the prevention and/or treatment of cardiac diseases in felinesBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2021·Granted Nov 28, 2023·1 cites·17 claims
- 0476US9308197B2Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in catsSTARK MARCUS·Filed 2013·Granted Apr 12, 2016·3 cites·12 claims
- 0575US10441597B2Ciclesonide for the treatment of airway disease in horsesBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2018·Granted Oct 15, 2019·1 cites·21 claims
- 0675US9918995B2Ciclesonide for the treatment of airway disease in horsesBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2013·Granted Mar 20, 2018·2 cites·20 claims
- 0774US9585873B2Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in catsSTARK MARCUS·Filed 2014·Granted Mar 7, 2017·2 cites·14 claims
- 0874US8772278B2Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in catsSTARK MARCUS·Filed 2007·Granted Jul 8, 2014·2 cites·6 claims
- 0973US10258634B2Ciclesonide for the treatment of airway disease in horsesBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2016·Granted Apr 16, 2019·1 cites·27 claims
- 1071US11083731B2Meloxicam for the treatment of respiratory diseases in pigsBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2019·Granted Aug 10, 2021·0 cites·8 claims
- 1166US2025195525A1Angiotensin ii receptor antagonist for the prevention of systemic diseases in catsBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2024·Application pending·0 cites
- 1263US10925964B2Pharmaceutical formulation comprising ciclesonideAVEN MICHAEL·Filed 2013·Granted Feb 23, 2021·0 cites·6 claims
- 1361US2024050456A1Use of sglt-2 inhibitors for the prevention and/or treat-ment of cardiac diseases in felinesBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2023·Application pending·0 cites
- 1460US2024390332A1Combination treatment and/or prevention of renal diseases and/or hypertension in non-human mammals comprising one or more SGLT-2 inhibitors and telmisartanBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2024·Application pending·0 cites
- 1559US2024390317A1Combination treatment and/or prevention of cardiac diseases in non-human mammals comprising one or more sglt-2 inhibitors and pimobendan and/or telmisartanBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2024·Application pending·0 cites
- 1658US10548901B2Meloxicam for the treatment of respiratory diseases in pigsBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2018·Granted Feb 4, 2020·0 cites·9 claims
- 1757US2008280840A1Meloxicam for the treatment of respiratory diseases in pigsBOEHRINGER INGELHEIM VETMED·Filed 2008·Application pending·0 cites
- 1852US2014179639A1Meloxicam for the treatment of respiratory diseases in pigsLANG INGO·Filed 2014·Application pending·0 cites
- 1952US2024398845A1Use of sglt-2 inhibitors for the prevention and/or treatment of cardiac diseases in non-human mammals excluding felines, in particular caninesBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2022·Application pending·0 cites
- 2052US2024307426A1Use of sglt-2 inhibitors for the prevention and/or treatment of renal diseases in non-human mammalsBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2022·Application pending·0 cites
- 2150US2005187213A1Meloxicam for the treatment of respiratory diseases in pigsBOEHRINGER INGELHEIM VETMED·Filed 2005·Application pending·0 cites
- 2249US2014228287A11-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-piperidin-1-yl]-axanthine for the treatment of a metabolic disorder of a predominantly carnivorous non-human animalDE VRIES FRERICH·Filed 2014·Application pending·0 cites
- 2348US2010190805A1Preparation for the treatment of equine laminitisBOEHRINGER INGELHEIM VETMED·Filed 2008·Application pending·0 cites
- 2447US2014171415A1Funny current (if) inhibitors for use in a method of treating and preventing heart disease in canineKLEY SASKIA·Filed 2013·Application pending·0 cites
- 2544US2011237532A11-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-piperidin-1-yl]-xanthine for the treatment of a metabolic disorder of a predominantly carnivorous non-human animalBOEHRINGER INGELHEIM VETMED·Filed 2011·Application pending·0 cites
- 2644US2016346288A11-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-piperidin-1-yl]-xanthine for the treatment of a metabolic disorder of a predominantly carnivorous non-human animalBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2016·Application pending·0 cites
- 2740US2005245510A1Use of meloxicam formulations in veterinary medicineBOEHRINGER INGELHEIM VETMED·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ingo Lang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →